SPP1 and melanoma: Therefore, the evaluation of MMPs circulating levels, and in particular the use of OPN and MMP-9 as circulating biomarkers, may improve the current diagnostic strategies for melanoma and predict the aggressiveness of tumors, in order to personalize the therapeutic approach for the patients.